Abstract
Background: The influenza virus is one of the most critical threats to public health with major economic impact. Though annual influenza vaccination is currently the most effective prevention strategy against flu epidemics and pandemics, the mutational evolution of the influenza virus tends to reduce the effectiveness of strain-specific vaccines. Methods: For past decades, a broad spectrum of potentially universal influenza vaccines has been thoroughly investigated to suppress different strains and subtypes of influenza virus concomitantly. Universal influenza vaccines were attempted to be designed to target conserved regions of surface receptors to provide the necessary preventive strategy against new influenza outbreaks. Conclusion: Notably, the influenza hemagglutinin (HA) receptor has evolutionary conserved domains that can serve as basis for the rational design of a universal influenza vaccine. In this review, we examine recent studies on HA-based universal influenza vaccines and address their molecular mechanism.
Keywords: Influenza virus, universal influenza vaccine, hemagglutinin (HA), antiviral immunity.
Current Pharmaceutical Design
Title:A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza Vaccine
Volume: 22 Issue: 23
Author(s): Thanh D. Van, Nhut Tran, Ly Le and Frank Eisenhaber
Affiliation:
Keywords: Influenza virus, universal influenza vaccine, hemagglutinin (HA), antiviral immunity.
Abstract: Background: The influenza virus is one of the most critical threats to public health with major economic impact. Though annual influenza vaccination is currently the most effective prevention strategy against flu epidemics and pandemics, the mutational evolution of the influenza virus tends to reduce the effectiveness of strain-specific vaccines. Methods: For past decades, a broad spectrum of potentially universal influenza vaccines has been thoroughly investigated to suppress different strains and subtypes of influenza virus concomitantly. Universal influenza vaccines were attempted to be designed to target conserved regions of surface receptors to provide the necessary preventive strategy against new influenza outbreaks. Conclusion: Notably, the influenza hemagglutinin (HA) receptor has evolutionary conserved domains that can serve as basis for the rational design of a universal influenza vaccine. In this review, we examine recent studies on HA-based universal influenza vaccines and address their molecular mechanism.
Export Options
About this article
Cite this article as:
D. Van Thanh, Tran Nhut, Le Ly and Eisenhaber Frank, A Perspective on Rational Designs of a Hemagglutinin Based Universal Influenza Vaccine, Current Pharmaceutical Design 2016; 22 (23) . https://dx.doi.org/10.2174/1381612822666160419144352
DOI https://dx.doi.org/10.2174/1381612822666160419144352 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Therapeutic Potential of Animal β-hairpin Antimicrobial Peptides
Current Medicinal Chemistry The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Current Pharmaceutical Design LC-MS/MS Identification and Structural Characterization of Main Biodegradation Products of Nitroproston - A Novel Prostaglandin-based Pharmaceutical Compound
Drug Metabolism Letters Pathogenesis of Major Depression by Stress Induced Hyperactivity of Hypothalmic-pituitary Adrenal Axis Mediated by Dysregulations of Neurotransmitter, Innate Immune Systems and Altered Brain micro RNA Expressions
Current Psychiatry Reviews Trends of SAPHO Therapy: Should we be Content?
Current Rheumatology Reviews Erythropoietin Directly Affects Human Macrophage Functionality
Current Pharmaceutical Biotechnology B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Withdrawal Notice: COVID-19: Outbreak to Global
Anti-Infective Agents Mechanisms to Inhibit Matrix Metalloproteinase Activity: Where are we in the Development of Clinically Relevant Inhibitors?
Recent Patents on Anti-Cancer Drug Discovery Thiazolidine: A Potent Candidate for Central Nervous System Diseases
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Neuropharmacology Unveiling mRNA Changes During Meiotic Progression and Pre-Implantation Development: Help from Large Animal Models
Current Pharmaceutical Design Neuroprotective Effects of Tetracyclines: Molecular Targets, Animal Models and Human Disease
CNS & Neurological Disorders - Drug Targets Encapsulation of Imatinib in Targeted KIT-5 Nanoparticles for Reducing its Cardiotoxicity and Hepatotoxicity
Anti-Cancer Agents in Medicinal Chemistry Novel Agents in the Management of Mycobacterium Tuberculosis Disease
Current Medicinal Chemistry Oxidative Stress Modulation Through Habitual Physical Activity
Current Pharmaceutical Design Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases
Current Genomics An Overview of the Treatment Contributions Measured Globally for the COVID-19 Outbreak
Coronaviruses Synthesis and Pharmacological Studies of Novel 3-Substituted Indole Derivatives as Potential Anti-Inflammatory and Analgesic Agents
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)